Per a court order, HHS is required to restore this website to its version as of 12:00 AM on January 29, 2025. Information on this page may be modified and/or removed in the future subject to the terms of the court’s order and implemented consistent with applicable law. Any information on this page promoting gender ideology is extremely inaccurate and disconnected from truth. The Trump Administration rejects gender ideology due to the harms and divisiveness it causes. This page does not reflect reality and therefore the Administration and this Department reject it.

Increase the proportion of adults with diabetes who get a yearly urinary albumin test — D‑05

Status: Improving

  
Image
Improving

Most Recent Data:
52.7 percent (2022)

Target:
66.4 percent 1

Desired Direction:
Increase desired

Baseline:
48.4 percent of Medicare beneficiaries with diabetes mellitus had urinary albumin testing in 2016 2

Increase the proportion of adults with diagnosed diabetes who receive an annual urinary albumin test

Target-Setting Method
Projection

Summary

The goal of screening for high levels of albumin in the urine is to help prevent end-stage kidney disease (ESKD) in people with diabetes. Finding high levels of this protein in urine is an effective way to identify early kidney damage caused by diabetes. This can lead to interventions to slow kidney damage or stop it from getting worse.

Workgroup: Diabetes Workgroup



1. Target has been revised. See Data Methodology and Measurement for more information.

2. Baseline has been revised. See Data Methodology and Measurement for more information.